Identification of the HLA-A*11:463 allele in a Chinese patient and his father.

HLA-A*11:463 has one nucleotide change from HLA-A*11:01:01:01 at nucleotide 508 changing Lysine (146) to Glutamine.

Identification of the novel HLA-C*01:02:86 allele in a Chinese individual.

HLA-C*01:02:86 has one synonymous nucleotide C > T change from HLA-C*01:02:01:01 at nucleotide 879 (residue 269 Proline).

Detection of an HLA-C*01 variant, HLA-C*01:212, in a Chinese individual.

HLA-C*01:212 differs from HLA-C*01:02:01:01 by two non-synonmous nucleotide changes at positions 368 and 379 in exon 3.

Identification of the novel allele HLA-B*13:157 by sequence-based typing.

HLA-B*13:157 has one nucleotide change from HLA-B*13:02:01:01 at nucleotide 323 changing Tyrosine to Phenylalanine at residue 84.

A novel HLA-C allele, HLA-C*15:244.

HLA-C*15:244 has one nucleotide change from HLA-C*15:05:01:01 at nucleotide 308 changing Arginine to Glutamine at residue 79.

Characterization of the novel allele HLA-B*35:251:02.

HLA-B*35:251:02 has one nucleotide change from HLA-B*35:22:01:01 at nucleotide 363 changing Serine to Arginine at residue 97.

Recognition of the HLA-A*11:398 allele in a Chinese patient and his sister.

HLA-A*11:398 has one nonsynonymous nucleotide change from HLA-A*11:01:01:01 at nucleotide 709, changing Isoleucine 213 to Valine.

Sequence-based typing identification of the novel allele HLA-B*40:482.

HLA-B*40:482 has one nucleotide change from HLA-B*40:06:01:01 at nucleotide 430 changing glycine to arginine at residue 120.

Identification of the novel HLA-A*02:981 allele by sequencing-based typing.

One nucleotide replacement at position 728 of HLA-A*02:07:01 results in a novel allele, HLA-A*02:981.

Recognization of the HLA-A*24:516 allele in a Chinese patient and his daughter.

HLA-A*24:516 has one nucleotide change from HLA-A*24:02:01:01 at nucleotide 194 where Alanine (41) is changed to Glycine.

Sequence-based typing identification of the novel allele HLA-A*30:170.

HLA-A*30:170 has one nucleotide change from HLA-A*30:01:01:01 at nucleotide 755 where Threonine T (228) is changed to Methionine M.

Identification of the novel HLA-A*11:361:02 allele in a Chinese patient.

HLA-A*11:361:02 has one nucleotide change from HLA-A*11:01:01:01 at nucleotide 486 where Methionine (138) is changed to Isoleucine.

[Spectroscopic study of metal coordination compounds with 1,2-trans-(4-pyridyl)ethene].

In the present article, three kinds of metal-organic coordination compounds were synthesized between 1,2-trans-(4-pyridyl)ethene (dpe) and sulfate of Cu(II), Zn(II) and Cd(I) by hydrothermal reactions. Infrared, Raman and ultraviolet-visible spectra of dpe and its metal--organic complexes were studied. Assignments of the main FTIR and Raman bands were done in detail. The relationship between these characteristic bands and the structure of ligands and coordination compounds was discussed. In the FTIR spectra, the co-vibration absorption band of C-C and C-N for dpe shifts to the higher wavenumbers for three metal-organic coordination compounds, respectively. In the Raman spectra, the corresponding vibration bands of C-N, C=C, C-C and C-H were also observed to shift to higher wavenumbers. In the UV-visible absorption spectra, Zn-dpe and Cd-dpe has an absorption peak which could be attributed to the ligand absorption itself. However, two absorption peaks were observed for the complex of Cu-dpe, which were ascribed to the ligand absorption band and d-d electronic transition in the coordination compound. This indicates that there is a great change in the absorption spectra for the same ligand but with different metal ions.

[Spectroscopy of Ag(I), Cd(II) complexes with 4-mercaptopyridine].

In the present article, two kinds of metal-organic coordination compounds were synthesized between 4-mercaptopyridine (4-MPy) and nitrate of Ag(I) and Cd(II) by a general solution reaction and evaporation. 4-mercaptopyridine and two transition metal complexes were investigated by means of infrared, Raman and ultraviolet-visible spectroscopic techniques, respectively. Assignments of the main FTIR and Raman bands were carried out in detail. The relationship between those characteristic bands and the structure of ligands and coordination compounds was discussed. In the FTIR spectra, the co-vibration absorption band of nu(C==C) and nu(C==N), for 4-MPy at 1 459 cm(-1) blue-shifted to 1 464 cm(-1) for both the metal-organic coordination compounds, respectively. The Raman spectra, for the two coordination compounds, at 1 004 and 1 008 cm(-1), which can be assigned to ring breathing vibration, at 1 617 and 1 615 cm ', which can be assigned to ring flex vibration, and at 720 and 720 cm(-1), which can be assigned to the composite vibration of beta(C--C) and nu(C--S) are similar, respectively.